会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • PYRAZOLOPYRIMIDINE DERIVATIVES AND USES AS ANTICANCER AGENTS
    • 吡唑并嘧啶衍生物和作为抗原剂的用途
    • WO2012097196A1
    • 2012-07-19
    • PCT/US2012/021144
    • 2012-01-12
    • ACEA BIOSCIENCES INC.MAO, LongZHAO, LiLIU, JiaWANG, XiaoboXU, Xiao
    • MAO, LongZHAO, LiLIU, JiaWANG, XiaoboXU, Xiao
    • C07D487/04A61K31/519A61P35/00
    • C07D487/04
    • Novel compounds having a fused pyrazolopyrimidine derivatives and related fused ring systems are disclosed. The compounds inhibit growth of a variety of types of cancer cells, and are thus useful for treating cancer. Pharmaceutical compositions, and methods of using these compounds and compositions to treat cancer and other diseases related to the dysregulation of kinase (such as Aurora A, Aurora B, Aurora C, cMet, JAK2, ROS1, but not limited to) pathways are disclosed. Efficacy of these compounds is demonstrated with a system for monitoring cell growth/migration, which shows they are potent inhibitors of growth and/or migration of cancer cells. Compositions comprising these compounds, and methods to use these compounds and compositions for treatment of cancers, are disclosed.
    • 公开了具有稠合吡唑并嘧啶衍生物和相关稠环体系的新型化合物。 这些化合物抑制多种类型的癌细胞的生长,因此可用于治疗癌症。 公开了药物组合物和使用这些化合物和组合物治疗与激酶失调相关的癌症和其它疾病(如Aurora A,Aurora B,Aurora C,cMet,JAK2,ROS1但不限于)途径的方法。 通过用于监测细胞生长/迁移的系统来证明这些化合物的功效,这表明它们是癌细胞的生长和/或迁移的有效抑制剂。 公开了包含这些化合物的组合物,以及使用这些化合物和用于治疗癌症的组合物的方法。
    • 10. 发明申请
    • METHOD FOR ASSAYING FOR NATURAL KILLER, CYTOTOXIC T- LYMPHOCYTE AND NEUTROPHIL-MEDIATED KILLING OF TARGET CELLS USING REAL-TIME MICROELECTRONIC CELL SENSING TECHNOLOGY
    • 使用实时微电解细胞感测技术测定天然杀伤剂,CYTOTOXIC T淋巴细胞和靶向细胞的中性粒细胞杀伤的方法
    • WO2006015387A2
    • 2006-02-09
    • PCT/US2005/027891
    • 2005-08-04
    • XU, XiaoABASSI, YamaWANG, Xiaobo
    • XU, XiaoABASSI, YamaWANG, Xiaobo
    • C12M1/34H01M4/50
    • G01N33/4836
    • The present invention includes a method of measuring cytolytic activity including providing a device capable of monitoring cell-substrate impedance operably connected to an impedance analyzer, adding target cells to at least one well of the device, adding effector cells to the at least one well, monitoring impedance of the at least one well and optionally determining a cell index from the impedance, wherein monitoring impedance includes measuring impedance during at least one time point before and at least one time point after adding effector cells, and determining viability of said target cells after adding effector cells by comparing the impedance or optionally the cell index at the at least one time point after adding effector cells to the impedance or optionally the cell index at the at least one time point before adding effector cells.
    • 本发明包括测量细胞溶解活性的方法,包括提供能够监测可操作地连接到阻抗分析仪的细胞 - 基底阻抗的装置,将靶细胞添加到装置的至少一个孔中,将效应细胞添加到至少一个孔, 监测所述至少一个井的阻抗并且可选地从所述阻抗确定细胞指数,其中监测阻抗包括在加入效应细胞之前和至少一个时间点之前的至少一个时间点之前测量阻抗,以及在确定所述靶细胞之后的存活力 通过在添加效应细胞之前在至少一个时间点将效应细胞添加到阻抗或任选地在至少一个时间点的细胞指数之后,比较阻抗或任选地在至少一个时间点处的细胞指数来添加效应细胞。